欧洲生物生产市场预测至 2030 年 - 区域分析 - 按产品（生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等）、应用（类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等）、设备（上游设备、下游设备、生物反应器、消耗品和配件）和最终用户（生物制药公司、合同制造组织等）
慢性病患病率上升推动欧洲生物生产市场发展
心血管疾病 (CVD)、神经系统疾病、自身免疫性疾病和癌症是全球导致死亡和残疾的慢性疾病。根据世界卫生组织 (WHO) 的数据，心血管疾病是全球第一大死亡原因，每年约夺走 1790 万人的生命。癌症也是全球死亡的主要原因之一，影响着大量人口；因此，它给社会带来了巨大的经济负担。根据世界卫生组织的数据，2020 年全球约有 1000 万人死于癌症。然而，越来越多的针对开发有效治疗方法的研究正在对市场增长产生积极影响。基因疗法和细胞疗法正在改变癌症治疗格局；例如，诺华的 Kymriah 用于治疗弥漫性大 B 细胞淋巴瘤。
此外，患者、专家、初级保健医生和其他医疗保健专业人员将生物仿制药视为有效且安全的药物，这推动了对生物仿制药的需求。此外，生物仿制药有助于改善数百万患者的生活，同时每年为医疗保健系统节省数十亿美元。它们是治疗许多疾病的有效且具有成本效益的选择，包括慢性皮肤病和肠道疾病，如克罗恩病、牛皮癣、肠易激综合征和结肠炎；糖尿病；自身免疫性疾病；癌症；肾脏疾病；关节炎。
随着慢性病的患病率迅速上升，过去五年来，治疗危及生命的疾病对生物生产的需求迅速增长，从而推动了生物生产市场的发展。
欧洲生物生产市场概览
欧洲生物生产市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。欧洲在全球生物生产市场中占有重要地位，预计在 2022-2030 年期间将实现显著的复合年增长率。慢性病患病率的不断上升导致产品上市和批准数量不断增加，技术进步和投资不断增加，从而促进了该地区的市场增长。
生物仿制药引入了竞争并提高了生物制剂的可负担性，最终带来了节约和增值服务，以支持患者护理和医疗保健行业。医疗保健专业人员可以以更低的成本用高质量的生物制剂治疗更多患者。由于具有巨大的成本节约潜力，德国卫生部出台了一项新法律，以增加生物仿制药的采用。由于一些欧盟 (EU) 国家允许药剂师替代生物仿制药，这将代表实践的重大变化，尤其是对德国而言。此外，德国法兰克福德国国际诊所 PHI 骨科物理治疗中心、德国慕尼黑 CBC Health 等医疗保健提供商以及其他提供商提供干细胞疗法，用于治疗糖尿病视网膜病变、视神经炎和类风湿性关节炎等各种慢性疾病。预计这将在未来几年增加细胞疗法的采用。此外，国际参与者之间越来越多的合作伙伴关系也促进了市场增长。例如，2020 年 11 月，日立化学先进治疗解决方案有限责任公司和 apceth Biopharma GmbH 扩大了与 bluebird bio 的合作关系，签订了多种疗法的临床和商业供应的长期开发和制造服务协议，包括扩大欧洲 ZYNTEGLO 的商业药品制造能力，ZYNTEGLO 是一种用于输血依赖性 β-地中海贫血 (TDT) 的一次性基因疗法。因此，随着德国政府越来越多地采用生物仿制药，市场预计将蓬勃发展。
欧洲生物生产市场收入及预测至 2030 年（百万美元）
欧洲生物生产市场细分
欧洲生物生产市场分为产品、应用、设备、最终用户和国家。
根据产品，欧洲生物生产市场细分为生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等。生物制剂和生物仿制药部门在 2022 年占据了欧洲生物生产市场的最大份额。
在应用方面，欧洲生物生产市场细分为类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等。癌症部门在 2022 年占据了欧洲生物生产市场的最大份额。
按设备划分，欧洲生物生产市场分为上游设备、下游设备、生物反应器以及耗材和配件。 2022 年，消耗品和配件部门占据了欧洲生物生产市场的最大份额。
就最终用户而言，欧洲生物生产市场分为生物制药公司、合同制造组织和其他。2022 年，生物制药公司部门占据了欧洲生物生产市场的最大份额。
按国家/地区划分，欧洲生物生产市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。2022 年，德国占据了欧洲生物生产市场份额的主导地位。
Lonza Group AG、bbi-biotech GmbH、Danaher Corp、Sartorius AG、FUJIFILM Irvine Scientific Inc、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd 和 Bio-Rad Laboratories Inc. 是欧洲生物生产市场的一些领先公司。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Europe Market Analysis
5.1 Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Europe: Bioproduction Market
10.1.1 Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Germany: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Germany: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Germany: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Germany: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Germany: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 UK: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 UK: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 UK: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 UK: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 UK: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 France: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 France: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 France: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 France: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Italy: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Italy: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Italy: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Italy: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 Spain: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 Spain: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 Spain: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 Spain: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Europe: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Europe: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Europe: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Europe: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Europe Bioproduction Market Segmentation
Table 2. Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. UK Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. France Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. France Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Spain Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Europe Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Europe Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Europe Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Europe Bioproduction Market Segmentation, By Country
Figure 2. Europe Bioproduction Market: Key Industry Dynamics
Figure 3. Europe Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Germany: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. UK: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. France: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Italy: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Spain: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Europe: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. bbi-biotech GmbH
2. Bio-Rad Laboratories Inc
3. Danaher Corp
4. F. Hoffmann-La Roche Ltd
5. FUJIFILM Irvine Scientific Inc
6. Lonza Group AG
7. Merck KGaA
8. Sartorius AG
9. Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.